期刊文献+

微小RNA-128-3p靶向调控高尔基体膜蛋白1对肺腺癌细胞增殖的作用 被引量:1

Targeted regulation of GOLM1 by miR-128-3p on proliferation of lung adenocarcinoma cells
下载PDF
导出
摘要 目的:观察微小RNA-128-3p(miR-128-3p)和高尔基体膜蛋白1(GOLM1)在肺腺癌细胞系中的表达特征,探讨miR-128-3p是否通过介导GOLM1调控肺腺癌细胞的增殖。方法:选择人肺癌细胞系SK-LU-1和A549、人永生化肺上皮细胞系16HBE,对SK-LU-1和A549分别建立miR-128-3p inhibitor组、siRNA-GOLM1组,并分别设立空白对照组,应用Western blot法检测GOLM1和增殖细胞核抗原(PCNA)的表达,应用实时荧光定量PCR法检测miR-128-3p的表达,应用CCK-8检测细胞增殖活性,挽救实验观察小干扰RNA-GOLM1逆转miR-128-3p inhibitor对PCNA表达的影响。结果:肺腺癌细胞系SK-LU-1和A549中miR-128-3p的表达量均明显低于16HBE,GOLM1和PCNA的表达量均明显高于16HBE(均P<0.05)。肺腺癌细胞系SK-LU-1和A549中,miR-128-3p inhibitior组中GOLM1的表达均明显高于空白对照组(均P<0.05),siRNA-GOLM1组的PCNA的表达量均明显低于空白对照组(均P<0.05),siRNA-GOLM1组在72 h开始细胞增殖活性均低于空白对照组(均P<0.05),均持续至96 h(均P<0.05),挽救实验显示干扰GOLM1可部分逆转miR-128-3p inhibitor对细胞增殖的促进作用(均P<0.05)。结论:肺腺癌细胞系中miR-128-3p低表达、GOLM1高表达,miR-128-3p靶向负调控GOLM1抑制肺腺癌细胞的增殖。 Objective:To observe the expression characteristics of microRNA-128-3p(miR-128-3p)and Golgi membrane protein 1(GOLM1)in lung adenocarcinoma cell lines,and to investigate whether miR-128-3p regulates lung adenocarcinoma cell proliferation by mediating GOLM1.Methods:Human lung cancer cell lines SK-LU-1 and A549 and human immortalized lung epithelial cell line 16HBE were selected.MiR-128-3p inhibitor group and siRNA-GOLM1 group were established respectively for SK-LU-1 and A549,and a blank control group was established respectively.GOLM1 and proliferating cell nuclear antigen(PCNA)were detected by Western blot,and miR-128-3p was detected by qRT-PCR,and the cell proliferation activity was detected by CCK-8.Results:The expression of miR-128-3p were significantly lower in both lung adenocarcinoma cell lines SK-LU-1 and A549 than that of 16HBE(all P<0.05),and the expressions of GOLM1 and PCNA were significantly higher in both lung adenocarcinoma cell lines SK-LU-1 and A549 than that of 16HBE(all P<0.05).GOLM1 was significantly higher in miR-128-3p inhibitior group than that of blank control group of SK-LU-1 and A549(all P<0.05).The expression of PCNA was significantly lower in the siRNA-GOLM1 group than that in the blank control group of SK-LU-1 and A549(all P<0.05).The cell proliferation activity was lower in the siRNA-GOLM1 group than that in the blank control group at 72 hours of SK-LU-1 and A549,and lasted until 96 hours(all P<0.05).The rescue experiments showed that interfering with GOLM1 could partially reverse the promotion effect of miR-128-3p inhibitor on cell proliferation(all P<0.05).Conclusion:MiR-128-3p is lowly expressed and GOLM1 is highly expressed in lung adenocarcinoma cell lines.MiR-128-3p inhibits the proliferation of lung adenocarcinoma cells by targeting GOLM1.
作者 崔文馨 赵晓辉 高蔚然 王娜 CUI Wenxin;ZHAO Xiaohui;GAO Weiran;WANG Na(Outpatient Blood Collection Room,the First Affiliated Hospital of Jinzhou Medical University,Jinzhou 121000,China)
出处 《陕西医学杂志》 CAS 2023年第4期385-389,共5页 Shaanxi Medical Journal
基金 中国医疗手牵手工程委员会-北京医学奖励基金会资助项目(YXJL-2021-1092-0640)。
关键词 肺腺癌 细胞系 微小RNA-128-3p 高尔基体膜蛋白1 细胞增殖 调控 Lung adenocarcinoma Cell line miR-128-3p Golgi membrane protein 1 Cell proliferation Regulation
  • 相关文献

参考文献6

二级参考文献41

  • 1Yoshifumi Baba,Masayuki Watanabe,Naoya Yoshida,Hideo Baba.Neoadjuvant treatment for esophageal squamous cell carcinoma[J].World Journal of Gastrointestinal Oncology,2014,6(5):121-128. 被引量:17
  • 2Caterina Pozzan,Romilda Cardin,Marika Piciocchi,Nora Cazzagon,Gemma Maddalo,Veronica Vanin,Anna Giacomin,Patrizia Pontisso,Umberto Cillo,Fabio Farinati.Diagnostic and prognostic role of SCCA ‐ IgM serum levels in hepatocellular carcinoma ( HCC )[J]. J Gastroenterol Hepatol . 2014 (8) 被引量:1
  • 3Rebecca Siegel,Deepa Naishadham,Ahmedin Jemal.Cancer statistics, 2013[J]. CA: A Cancer Journal for Clinicians . 2013 (1) 被引量:122
  • 4Zhong-Bo Han,Hong-Yuan Chen,Jun-Wei Fan,Jun-Yi Wu,Hua-Mei Tang,Zhi-Hai Peng.Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation[J].Journal of Cancer Research and Clinical Oncology.2012(1) 被引量:2
  • 5Sean F. Altekruse,Katherine A. McGlynn,Marsha E. Reichm.Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005. Japanese Journal of Clinical Oncology . 2009 被引量:5
  • 6Gupta Samir,Bent Stephen,Kohlwes Jeffrey.Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Annals of Internal Medicine . 2003 被引量:2
  • 7Patrick Reichl,Meng Fang,Patrick Starlinger,Katharina Staufer,Rudolf Nenutil,Petr Muller,Kristina Greplova,Dalibor Valik,Steven Dooley,Christine Brostjan,Thomas Gruenberger,Jiayun Shen,Kwan Man,Michael Trauner,Jun Yu,Chun Fang Gao,Wolfgang Mikulits.Multicenter analysis of soluble A xl reveals diagnostic value for very early stage hepatocellular carcinoma[J]. Int. J. Cancer . 2015 (2) 被引量:2
  • 8Athina Chounta,Christofer Ellinas,Vassiliki Tzanetakou,Fani Pliarhopoulou,Virginia Mplani,Angelos Oikonomou,Kostantinos Leventogiannis,Evangelos J. Giamarellos‐Bourboulis.Serum soluble urokinase plasminogen activator receptor as a screening test for the early diagnosis of hepatocellular carcinoma[J]. Liver Int . 2015 (2) 被引量:1
  • 9Karim Y. A. Shaheen,Abeer I. Abdel-Mageed,Eslam Safwat,Ashraf M. AlBreedy,Shigeru Marubashi.The Value of Serum Midkine Level in Diagnosis of Hepatocellular Carcinoma[J]. International Journal of Hepatology . 2015 被引量:1
  • 10Nicolas Poté,Fran?ois Cauchy,Miguel Albuquerque,Hélène Voitot,Jacques Belghiti,Laurent Castera,Hervé Puy,Pierre Bedossa,Valérie Paradis.Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion[J]. Journal of Hepatology . 2014 被引量:2

共引文献125

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部